COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

BACKGROUND: Lateral flow device (LFD) viral antigen immunoassays have been developed around the world as diagnostic tests for SARS-CoV-2 infection. They have been proposed to deliver an infrastructure-light, cost-economical solution giving results within half an hour. METHODS: LFDs were initially re...

Descripción completa

Detalles Bibliográficos
Autor principal: Peto, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164528/
https://www.ncbi.nlm.nih.gov/pubmed/34101770
http://dx.doi.org/10.1016/j.eclinm.2021.100924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164528/
https://www.ncbi.nlm.nih.gov/pubmed/34101770
http://dx.doi.org/10.1016/j.eclinm.2021.100924

Ejemplares similares